Reference
Meloni A, et al. A Cost-Utility Analysis of Deferiprone Compared to Desferrioxamine and Deferasirox for the Treatment of Chronic Iron Overload in People with Thalassaemia: an Italian Adaptation of the Uk Model. 20th Congress of the European Haematology Association : abstr. P425, 11 Jun 2015. Available from: URL: http://learningcenter.ehaweb.org/eha/2015/20th/100661/alessia.pepe.a.cost-utility.analysis.of.deferiprone.compared.to.html?f=l5577p16m3
Rights and permissions
About this article
Cite this article
Deferiprone cost saving for chronic iron overload. PharmacoEcon Outcomes News 733, 11 (2015). https://doi.org/10.1007/s40274-015-2312-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2312-6